H Lochs

Summary

Affiliation: Humboldt University
Country: Germany

Publications

  1. ncbi Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI
    H Lochs
    IV Medizinische Klinik, Universitatsklinikum Charite, Humboldt Universitat, Berlin, Germany
    Gastroenterology 118:264-73. 2000
  2. ncbi Increased intestinal permeability in malnourished patients with liver cirrhosis
    K Norman
    Medizinische Klinik für Gastroenterologie, Infektiologie und Rheumatologie einschl Arbeitsbereich Ernährungsmedizin, Charite Universitatsmedizin Berlin, Campus Charite Mitte, Berlin, Germany
    Eur J Clin Nutr 66:1116-9. 2012
  3. ncbi Clinical relevance of measuring colonic permeability
    V Haas
    Charite University Clinic, Berlin, Germany
    Eur J Clin Invest 39:139-44. 2009
  4. ncbi Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn's disease but also ulcerative colitis
    C Buning
    Department of Gastroenterology, Hepatology and Endocrinology, Charite, Campus Mitte, Universitatsmedizin Berlin, Berlin, Germany
    Aliment Pharmacol Ther 26:1025-33. 2007
  5. ncbi Macroscopic appearance of intestinal angiodysplasias under antiangiogenic treatment with thalidomide
    J Bauditz
    Charite University Hospital, IVth Department of Medicine, Berlin, Germany
    Endoscopy 38:1036-9. 2006
  6. ncbi Immunization of cancer patients with autologous cancer-derived heat shock protein gp96 preparations: a pilot study
    S Janetzki
    IV Medizinische Klinik der Charitè, Humboldt Universitat zu Berlin, Berlin, Germany
    Int J Cancer 88:232-8. 2000
  7. ncbi ESPEN Guidelines on Enteral Nutrition: Gastroenterology
    H Lochs
    Department of Gastroenterology, Charite Universitatsmedizin, CCM, Berlin, Germany
    Clin Nutr 25:260-74. 2006
  8. ncbi Does passage of a patency capsule indicate small-bowel patency? A prospective clinical trial?
    M L Boivin
    Department of Gastroenterology, Hepatology and Endocrinology, Universitatsklinikum Charite, Humboldt University, Schumannstrasse 20 21, 10117 Berlin, Germany
    Endoscopy 37:808-15. 2005
  9. ncbi Small bowel involvement in Crohn's disease: a prospective comparison of wireless capsule endoscopy and computed tomography enteroclysis
    W A Voderholzer
    Medical Clinic IV Gastroenterology Hepatology Endocrinology Metabolism, Charite University Hospital, Humboldt University, Berlin, Germany
    Gut 54:369-73. 2005
  10. ncbi Possible role of MDR1 two-locus genotypes for young-age onset ulcerative colitis but not Crohn's disease
    T Fiedler
    Department of Gastroenterology, Hepatology and Endocrinology, Charite Universitatsmedizin Berlin, CCM, Chariteplatz 1, Berlin, 10117, Germany
    Eur J Clin Pharmacol 63:917-25. 2007

Detail Information

Publications61

  1. ncbi Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI
    H Lochs
    IV Medizinische Klinik, Universitatsklinikum Charite, Humboldt Universitat, Berlin, Germany
    Gastroenterology 118:264-73. 2000
    ..This study investigated if long-term treatment with high-dose mesalamine reduces the risk of clinical relapse of Crohn's disease after surgical resection...
  2. ncbi Increased intestinal permeability in malnourished patients with liver cirrhosis
    K Norman
    Medizinische Klinik für Gastroenterologie, Infektiologie und Rheumatologie einschl Arbeitsbereich Ernährungsmedizin, Charite Universitatsmedizin Berlin, Campus Charite Mitte, Berlin, Germany
    Eur J Clin Nutr 66:1116-9. 2012
    ..The objective of this study is to investigate whether malnutrition is associated with increased gastrointestinal permeability in liver cirrhosis reflected by altered urinary excretion of non-metabolizable sugar probes...
  3. ncbi Clinical relevance of measuring colonic permeability
    V Haas
    Charite University Clinic, Berlin, Germany
    Eur J Clin Invest 39:139-44. 2009
    ..The relevance of colonic permeability has not yet been adequately investigated. The aim of this study was to investigate the clinical value of sucralose excretion as indicator for colonic permeability in these patient groups...
  4. ncbi Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn's disease but also ulcerative colitis
    C Buning
    Department of Gastroenterology, Hepatology and Endocrinology, Charite, Campus Mitte, Universitatsmedizin Berlin, Berlin, Germany
    Aliment Pharmacol Ther 26:1025-33. 2007
    ..A recent study reported that a non-synonymous single nucleotide polymorphism (rs11209026, p.Arg381Gln) located in the IL23R gene is a protective marker for inflammatory bowel disease...
  5. ncbi Macroscopic appearance of intestinal angiodysplasias under antiangiogenic treatment with thalidomide
    J Bauditz
    Charite University Hospital, IVth Department of Medicine, Berlin, Germany
    Endoscopy 38:1036-9. 2006
    ..Thalidomide is a potent inhibitor of angiogenesis in experimental models. As angiodysplasias are a result of unregulated vessel growth, antiangiogenic treatment may inhibit growth of angiodysplasias...
  6. ncbi Immunization of cancer patients with autologous cancer-derived heat shock protein gp96 preparations: a pilot study
    S Janetzki
    IV Medizinische Klinik der Charitè, Humboldt Universitat zu Berlin, Berlin, Germany
    Int J Cancer 88:232-8. 2000
    ..These observations are entirely consistent with the murine experience and form a firm basis for future trials with clinical end points, using autologous, patient-specific HSP-peptide vaccines...
  7. ncbi ESPEN Guidelines on Enteral Nutrition: Gastroenterology
    H Lochs
    Department of Gastroenterology, Charite Universitatsmedizin, CCM, Berlin, Germany
    Clin Nutr 25:260-74. 2006
    ..In remission ONS is recommended only in steroid dependent patients in CD. In patients with SBS TF should be introduced in the adaptation phase and should be changed with progressing adaptation to ONS in addition to normal food...
  8. ncbi Does passage of a patency capsule indicate small-bowel patency? A prospective clinical trial?
    M L Boivin
    Department of Gastroenterology, Hepatology and Endocrinology, Universitatsklinikum Charite, Humboldt University, Schumannstrasse 20 21, 10117 Berlin, Germany
    Endoscopy 37:808-15. 2005
    ..The purpose of this prospective study was to investigate the feasibility and safety of the recently developed patency capsule, and its predictive value regarding the clinical relevance of radiographic small-bowel strictures...
  9. ncbi Small bowel involvement in Crohn's disease: a prospective comparison of wireless capsule endoscopy and computed tomography enteroclysis
    W A Voderholzer
    Medical Clinic IV Gastroenterology Hepatology Endocrinology Metabolism, Charite University Hospital, Humboldt University, Berlin, Germany
    Gut 54:369-73. 2005
    ..Wireless capsule endoscopy (WCE) offers endoscopic access to the small bowel and may therefore change diagnostic and therapeutic strategies in small bowel diseases...
  10. ncbi Possible role of MDR1 two-locus genotypes for young-age onset ulcerative colitis but not Crohn's disease
    T Fiedler
    Department of Gastroenterology, Hepatology and Endocrinology, Charite Universitatsmedizin Berlin, CCM, Chariteplatz 1, Berlin, 10117, Germany
    Eur J Clin Pharmacol 63:917-25. 2007
    ..The role of the single nucleotide polymorphisms (SNPs) on positions 2677G>T/A and 3435C>T of the multi-drug-resistance gene 1 (MDR1) in inflammatory bowel disease (IBD) remains unclear...
  11. ncbi Thalidomide for treatment of severe intestinal bleeding
    J Bauditz
    Charite University Hospital, IVth Department of Medicine, Berlin, Germany
    Gut 53:609-12. 2004
    ..These results indicate that thalidomide might be useful for patients with otherwise refractory intestinal bleeding...
  12. ncbi Spatial organisation of microbiota in quiescent adenoiditis and tonsillitis
    A Swidsinski
    Medizinische Klinik, Charité Humboldt Universität, CCM, Molekular genetisches Labor für polymikrobielle Infektionen und bakterielle Biofilme, Berlin, Germany
    J Clin Pathol 60:253-60. 2007
    ..The reasons for recurrent adenotonsillitis are poorly understood...
  13. ncbi Cost-effectiveness of a 3-month intervention with oral nutritional supplements in disease-related malnutrition: a randomised controlled pilot study
    K Norman
    Department of Gastroenterology, Hepatology and Endocrinology, Charite University Medicine, Berlin, Germany
    Eur J Clin Nutr 65:735-42. 2011
    ..We investigated whether post-hospital supplementation with ONS is cost-effective according to international benchmarks in malnourished patients...
  14. ncbi Glutamine-enriched total parenteral nutrition in patients with inflammatory bowel disease
    J Ockenga
    Department of Gastroenterology, Hepatology and Endocrinology, Medical School of Hannover, Germany
    Eur J Clin Nutr 59:1302-9. 2005
    ..However, human data supporting this assumption are missing...
  15. ncbi Nutritional assessment and management in hospitalised patients: implication for DRG-based reimbursement and health care quality
    J Ockenga
    Department of Gastroenterology, Hepatology and Endocrinology, Charite, Universitatsmedizin Berlin, Schumannstrasse 20 21, 10117 Berlin, Germany
    Clin Nutr 24:913-9. 2005
    ..The primary aim of this study was to evaluate the economic effect of a nutritional screening procedure on the identification and coding of malnutrition in the G-DRG system...
  16. ncbi Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 3020insC mutation?
    S Buhner
    Department of Gastroenterology, Hepatology, and Endocrinology, Campus Charite Mitte, Charite Universitatsmedizin Berlin, Schumannstr 20 21, 10117 Berlin, Germany
    Gut 55:342-7. 2006
    ..Recently, mutations of the capsase recruitment domain family, member 15 (CARD15) gene have been identified and associated with CD. We hypothesise that a CARD15 mutation may be associated with an impaired intestinal barrier...
  17. ncbi Bacterial biofilm within diseased pancreatic and biliary tracts
    A Swidsinski
    Innere Klinik, Gastroenterologie, Charite, 10098 Berlin, Germany
    Gut 54:388-95. 2005
    ..Bacterial community structures in human pancreatic and biliary tracts were evaluated...
  18. ncbi Chronic intermittent abdominal pain
    J Ockenga
    Gastroenterology, Hepatology and Endocrinology, , Schumannstrasse 20/21, 10117 Berlin, Germany
    Gut 54:1002, 1013. 2005
  19. ncbi Interaction between nutrition, intestinal flora and the gastrointestinal immune system
    H Lochs
    Medizinische Klinik mit Schwerpunkt Gastroenterologie, Hepatologie und Endokrinologie, Charit, Schumannstrasse 20-21, DE-10117 Berlin, Germany
    Nestle Nutr Workshop Ser Clin Perform Programme 10:179-85; discussion 185-8. 2005
  20. ncbi To feed or not to feed? Are nutritional supplements worthwhile in active Crohn's disease?
    H Lochs
    Medizinische Klinik mit Schwerpunkt Gastroenterologie, Hepatologie und Endokrinologie, Charite Universitatsmedizin Berlin, Schumannstr 20 21, D 10117 Berlin, Germany
    Gut 55:306-7. 2006
  21. ncbi European evidence based consensus on the diagnosis and management of Crohn's disease: special situations
    R Caprilli
    John Radcliffe Hospital, Oxford OX3 9DU, UK
    Gut 55:i36-58. 2006
    ..The second section on current management addresses treatment of active disease, maintenance of medically induced remission, and surgery of Crohn's disease...
  22. ncbi Assessment of suspected insulinoma by 48-hour fasting test: a retrospective monocentric study of 23 cases
    M Quinkler
    Clinical Endocrinology, Internal Medicine Center for Gastroenterology, Hepatology, and Endocrinology, Charite Campus Mitte, Charite Universitatsmedizin Berlin, Berlin, Germany
    Horm Metab Res 39:507-10. 2007
    ..The aim of our study was to evaluate retrospectively the percentage of positive 48-hour fasting tests in a large series of patients with insulinoma...
  23. ncbi Barrier function of the gut and multiple organ dysfunction after cardiac surgery
    J P Braun
    Department of Anesthesiology and Intensive Care, Charité Campus Mitte and Charité Virchow Klinikum, Charite Universitatsmedizin, Berlin, Germany
    J Int Med Res 35:72-83. 2007
    ..A reduced pre-operative functional mucosal surface may predict the early occurrence of MOD after surgery...
  24. ncbi [ESPEN guidelines on enteral nutrition--summary]
    T Schutz
    Charite Universitatsmedizin Berlin, Medizinische Klinik mit Schwerpunkt Gastroenterologie, Hepatologie und Endokrinologie, Berlin
    Z Gastroenterol 44:683-4. 2006
    ..dgem.de. The ESPEN guidelines enteral nutrition reflect the current medical knowledge in the field of enteral nutrition therapy and may help to decide when enteral nutrition is indicated and which therapeutic goals can be reached...
  25. ncbi ESPEN Guidelines on Enteral Nutrition: Geriatrics
    D Volkert
    Head Medical Science Division, Pfrimmer Nutricia, Erlangen, Germany
    Clin Nutr 25:330-60. 2006
    ..Altogether, it is strongly recommended not to wait until severe undernutrition has developed, but to start EN therapy early, as soon as a nutritional risk becomes apparent...
  26. ncbi Introductory to the ESPEN Guidelines on Enteral Nutrition: Terminology, definitions and general topics
    H Lochs
    Department of Gastroenterology, Hepatology and Endocrinology, Charite Universitatsmedizin Berlin, Germany
    Clin Nutr 25:180-6. 2006
    ..Additionally answers to more general questions, which might be important in most indications are dealt with, i.e. use of fibre containing and diabetes formulae...
  27. ncbi [Malnutrition in liver cirrhosis: impact of protein rich oral diet]
    M Pirlich
    , Hepatologie und Endokrinologie,
    Z Gastroenterol 44:344-5. 2006
  28. ncbi Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin
    C Prantera
    Operative Unit of Gastroenterology, St Camillo Forlanini Hospital, Rome, Italy
    Aliment Pharmacol Ther 23:1117-25. 2006
    ..Clinicians often employ antibiotics in Crohn's disease. Rifaximin is active against bacteria frequently found in the intestinal mucosa of Crohn's disease patients...
  29. ncbi [Enteral nutrition]
    M Pirlich
    Gastroenterologie, Hepatologie und Endokrinologie, , Germany
    Internist (Berl) 47:405-19; quiz 420-21. 2006
    ..e. specific amino acids, nucleotides or fatty acids to improve the immune function. These modified diets are used for specific indications which are highlighted in this article...
  30. ncbi [Hypogonadism despite of normal testosterone levels]
    J Bauditz
    Medizinische Klinik und Poliklinik, Universitätsklinikum Charité Campus Mitte, Berlin
    Internist (Berl) 46:334-40. 2005
    ..The patient was treated by combined radiochemotherapy and is in remission since 7 years...
  31. ncbi Covered transjugular intrahepatic portosystemic stents maintain lower portal pressure and require fewer reinterventions than uncovered stents
    J Ockenga
    Medizinische Klinik mit Schwerpunkt Gastroenterologie, Hepatologie und Endokrinologie, Charite Universitatsmedizin Berlin, Germany
    Scand J Gastroenterol 39:994-9. 2004
    ..The purpose of this study was to evaluate the patency, functional and haemodynamic results of expanded-polytetrafluoroethylene (ePTFE)-covered transjugular intrahepatic portosystemic shunts in patients with liver cirrhosis...
  32. ncbi Pseudoallergic reactions in chronic urticaria are associated with altered gastroduodenal permeability
    S Buhner
    Department of Gastroenterology, Hepatology, and Endocrinology, , Berlin, Germany
    Allergy 59:1118-23. 2004
    ..The underlying mechanisms seem to be independent of H. pylori infection...
  33. ncbi Replacement of conventional glucocorticoids by oral pH-modified release budesonide in active and inactive Crohn's disease: results of an open, prospective, multicenter trial
    T Andus
    Klinikum Stuttgart, Krankenhaus Bad Cannstatt, Stuttgart, Germany
    Dig Dis Sci 48:373-8. 2003
    ..In conclusion, switching from conventional GCS treatment to budesonide leads to a significant reduction of GCS related side effects in patients with CD without causing rapid deterioration of the disease...
  34. ncbi Time gated fluorescence spectroscopy in Barrett's oesophagus
    M A E J Ortner
    4th Medical Department, Charite University Hospital, Humboldt University, Berlin, Germany
    Gut 52:28-33. 2003
    ....
  35. ncbi [Tumour anorexia--tumour cachexia in case of gastrointestinal tumours: standards and visions]
    J Ockenga
    Medizinische Klinik mit Schwerpunkt Gastroenterologie, Hepatologie und Endokrinologie, Humboldt Universitat, Charite, Berlin, Germany
    Z Gastroenterol 40:929-36. 2002
    ..An algorithm of the current treatment strategies is given. In addition, we discuss new anabolic and anticatabolic agents (e.g. eicosapentanoic acid) and the results from first clinical trials...
  36. ncbi [Remicade in therapy of rheumatoid arthritis and Crohn diseases--no reason for panic]
    J R Kalden
    ,
    Z Rheumatol 61:466-8. 2002
  37. ncbi Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett's esophagus? A pilot study
    M A Ortner
    Department of Gastroenterology, Hepatology, Endocrinology, Metabolism and Nutrition, Medical Faculty Charité, Humboldt University, Berlin, Germany
    Endoscopy 34:611-6. 2002
    ....
  38. ncbi [Differential diagnosis of frequent pancreatic tumours with echo-enhanced power-Doppler sonography - presentation of case reports]
    S Rickes
    Medizinische Klinik mit Schwerpunkt Gastroenterologie, Hepatologie und Endokrinologie, , Germany
    Z Gastroenterol 40:235-40. 2002
    ..CONCLUSIONS: Pancreatic tumours have different vascularisation patterns in the echo-enhanced Power-Doppler sonography. These characteristics can be used for the differential diagnosis...
  39. ncbi Non-invasive evaluation of activity in inflammatory bowel disease by power Doppler sonography
    R Heyne
    Dept. of Gastroenterology, Hepatology and Endocrinology, , 10117 Berlin, Germany
    Z Gastroenterol 40:171-5. 2002
    ..A combination of B-mode and power Doppler sonography offers an additional noninvasive procedure for the determination of activity in patients with inflammatory bowel disease...
  40. ncbi Nutrition in the elderly
    M Pirlich
    , Medizinische Klinik mit Schwerpunkt Gastroenterologie, Hepatologie und Endokrinologie, Schumannstrasse 20/21, D-10117 Berlin, Germany
    Best Pract Res Clin Gastroenterol 15:869-84. 2001
    ..An improvement in the nutritional status can be achieved by simple methods such as the preparation of an adequate diet, hand feeding, additional sip feeding or enteral nutrition...
  41. ncbi Trimetrexate as biochemical modulator of 5-fluorouracil/leucovorin in advanced colorectal cancer: final results of a randomised European study
    C J A Punt
    University Medical Centre, St Radboud, Nijmegen, The Netherlands
    Ann Oncol 13:81-6. 2002
    ..Phase II trials have shown promising activity of 5-FU/LV/TMTX in patients with advanced colorectal cancer (ACC). This trial evaluated the effect of TMTX in combination with 5-FU/LV as first-line treatment in ACC...
  42. ncbi Thalidomide reduces tumour necrosis factor alpha and interleukin 12 production in patients with chronic active Crohn's disease
    J Bauditz
    Charite University Hospital, 4th Department of Medicine, Berlin, Germany
    Gut 50:196-200. 2002
    ..Suppression of tumour necrosis factor alpha (TNF-alpha) by thalidomide has been suggested as a possible mechanism. However, effects on other cytokines have not been adequately investigated...
  43. ncbi Dyslipemia in familial partial lipodystrophy caused by an R482W mutation in the LMNA gene
    H H Schmidt
    Charite Campus Mitte, Medizinische Klinik Gastroenterologie, Hepatologie und Endokrinologie, Berlin, Germany
    J Clin Endocrinol Metab 86:2289-95. 2001
    ..In conclusion, dyslipemia is an early and prominent feature in the presented lipodystrophic family carrying the R482W mutation within LMNA...
  44. ncbi Three novel mutations (P760L, L1305P, Q1351Stop) causing Wilson disease
    J Genschel
    , Med. Klinik m.S. Gastroenterologie, Hepatologie und Endokrinologie, Berlin, Germany
    Hum Mutat 17:156. 2001
  45. ncbi Improved assessment of body cell mass by segmental bioimpedance analysis in malnourished subjects and acromegaly
    M Pirlich
    Medizinische Klinik und Poliklinik, Abteilung Gastroenterologie, , , Germany
    Clin Nutr 22:167-74. 2003
    ..88 and 0.60; P<0.001 and <0.003, respectively). CONCLUSION: Segmental BIA improves the assessment of BCM in malnourished patients and acromegaly, but not in patients with severe fluid overload...
  46. ncbi The C/C(-13910) and G/G(-22018) genotypes for adult-type hypolactasia are not associated with inflammatory bowel disease
    C Buning
    Dept of Gastroenterology, Hepatology and Endocrinology, Charite, Humboldt University, Berlin, Germany
    Scand J Gastroenterol 38:538-42. 2003
    ..We utilized these two DNA genotypes to study their role in inflammatory bowel disease...
  47. ncbi Mutations in the NOD2/CARD15 gene in Crohn's disease are associated with ileocecal resection and are a risk factor for reoperation
    C Buning
    Department of Gastroenterology, Hepatology and Endocrinology, Charite, Campus Mitte, Humboldt University, Schumannstrasse 20 21, 10117 Berlin, Germany
    Aliment Pharmacol Ther 19:1073-8. 2004
    ..Mutations within the NOD2/CARD15 gene have recently been shown to be associated with Crohn's disease...
  48. ncbi Diagnostic yield of wireless capsule enteroscopy in comparison with computed tomography enteroclysis
    W A Voderholzer
    Dept of Medicine IV Gastroenterology Hepatology Endocrinology Metabolism, Charite University Hospital, Humboldt University, Berlin, Germany
    Endoscopy 35:1009-14. 2003
    ..In a prospective study, the diagnostic yield of wireless enteroscopy was therefore compared with computed tomography (CT) enteroclysis...
  49. ncbi The interleukin-25 gene located in the inflammatory bowel disease (IBD) 4 region: no association with inflammatory bowel disease
    C Buning
    Humboldt University, Berlin, Germany
    Eur J Immunogenet 30:329-33. 2003
    ....
  50. ncbi Splanchnic oxygen transport, hepatic function and gastrointestinal barrier after normothermic cardiopulmonary bypass
    J P Braun
    Department of Anesthesiology and Intensive Care, University Hospital Charite, Humboldt University, Berlin, Germany
    Acta Anaesthesiol Scand 48:697-703. 2004
    ....
  51. ncbi Prevalence of malnutrition in 1760 patients at hospital admission: a controlled population study of body composition
    U G Kyle
    Clinical Nutrition, Geneva University Hospital, Geneva, Switzerland
    Clin Nutr 22:473-81. 2003
    ..Serum albumin and BMI underestimated the prevalence of malnutrition in patients at hospital admission. Body composition measurements identified patients with low FFM and low or high BF reserves...
  52. ncbi Keratin 8 Y54H and G62C mutations are not associated with inflammatory bowel disease
    C Buning
    Department of Gastroenterology, Hepatology and Endocrinology, Universitatsmedizin Berlin, Charite, Campus Mitte, Schumannstrasse 20 21, D 10117 Berlin, Germany
    Dig Liver Dis 36:388-91. 2004
    ..Keratin 8 deficient mice display signs of colitis and diarrhoea characteristic for inflammatory bowel disease. Very recently, two keratin 8 mutations, Y54H and G62C, were identified...
  53. ncbi Differentiation of a pancreatic metastasis of a renal cell carcinoma from a primary pancreatic carcinoma by echo-enhanced power Doppler sonography
    B Flath
    Department of Oncology and Haematology, University Hospital Charité Campus Mitte, Humboldt University, Berlin, Germany
    Pancreatology 3:349-51. 2003
    ..We conclude that this technique can provide an important contribution to the diagnosis in this special instance. However, histology is the standard in the differential diagnosis of pancreatic tumours...
  54. ncbi [Hypophyseal ACTH-cell carcinoma after several surgical interventions and radiotherapy]
    I Heukamp
    Medizinische Klinik mit Schwerpunkt Gastroenterologie, Hepatologie und Endokrinologie der Charite Campus Mitte Berlin
    Dtsch Med Wochenschr 129:310-2. 2004
    ..The clinical examination was without abnormal findings apart from left temporal pain on pressure on the top of the skull...
  55. ncbi n-3, n-6, and n-9 polyunsaturated fatty acids--which composition in parenteral nutrition decreases severity of acute hemorrhagic necrotizing pancreatitis in rats?
    M Kilian
    Clinic of General, Visceral, Vascular and Thoracic Surgery, Charite Campus Mitte, Humboldt University of Berlin, Berlin, Germany
    Int J Colorectal Dis 21:57-63. 2006
    ..Acute pancreatitis often requires parenteral nutrition. Thus, we analyzed, using a randomized trial, whether different fatty acids in parenteral nutrition influence lipidperoxidation and histopathology in acute pancreatitis in rats...
  56. ncbi Endoscopic injection of mitomycin adsorbed on carbon particles for advanced esophageal cancer: a pilot study
    M A E Ortner
    Department of Gastroenterology Hepatology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
    Endoscopy 36:421-5. 2004
    ..The primary outcome parameter was survival time; secondary parameters were dysphagia and quality of life...
  57. ncbi [Pre- and probiotics]
    R Meier
    Medizinische Universitatsklinik, Abteilung für Gastroenterologie, Hepatologie und Ernährung, Kantonsspital, Liestal, Switzerland
    Ther Umsch 64:161-9. 2007
    ..Future studies should focus to determine the characteristics of a healthy gut and the evaluation of specific health benefits by well-designed, controlled human studies of adequate duration...
  58. ncbi A sensitive noninvasive method for monitoring successful liver-directed gene transfer of the low-density lipoprotein receptor in Watanabe hyperlipidemic rabbits in vivo
    U J F Tietge
    Department of Medicine and NWFZ, , Humboldt University, Berlin, Germany
    Gene Ther 11:574-80. 2004
    ..5-fold higher L/H ratios on day 30. This imaging method might be a useful strategy to obtain reliable data on functional transgene expression in clinical gene therapy trials of familial hypercholesterolemia...
  59. ncbi A randomised placebo controlled trial of pegylated interferon alpha in active ulcerative colitis
    H Tilg
    Department of Gastroenterology and Hepatology and Biostatistics, University Hospital Innsbruck, Austria
    Gut 52:1728-33. 2003
    ..We evaluated the safety of pegylated interferon alpha (PegIFN) and its role in induction of remission in patients with active ulcerative colitis, in a multicentre placebo controlled trial...
  60. ncbi [Practical tips for probiotics use by Prof. H. Lochs, Berlin. Deep effects]
    H Lochs
    MMW Fortschr Med 144:10. 2002
  61. ncbi Evidence supports nutritional support
    H Lochs
    Clin Nutr 25:177-9. 2006